Walleye Trading
GH icon

Walleye Trading’s Guardant Health GH Stock Holding History

Walleye Trading’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-55,000
Closed -$5.62M – 4335
2025
Q4 		$5.62M Sell
55,000
-14,000
-20% -$1.25M 0.01% 1224
2025
Q3 		$4.31M Buy
69,000
+28,300
+70% +$1.54M 0.01% 1329
2025
Q2 		$2.12M Buy
40,700
+40,200
+8,040% +$1.8M ﹤0.01% 1691
2025
Q1 		$21.3K Sell
500
-3,500
-88% -$151K ﹤0.01% 3781
2024
Q4 		$122K Sell
4,000
-12,000
-75% -$338K ﹤0.01% 3475
2024
Q3 		$367K Buy
16,000
+6,400
+67% +$181K ﹤0.01% 2708
2024
Q2 		$277K Buy
+9,600
New +$224K ﹤0.01% 2891
2024
Q1 		– Sell
-9,600
Closed -$260K – 4982
2023
Q4 		$260K Buy
9,600
+6,100
+174% +$160K ﹤0.01% 3601
2023
Q3 		$104K Sell
3,500
-1,400
-29% -$49.2K ﹤0.01% 3946
2023
Q2 		$175K Sell
4,900
-41,600
-89% -$1.19M ﹤0.01% 3496
2023
Q1 		$1.09M Buy
46,500
+37,400
+411% +$1.07M ﹤0.01% 2140
2022
Q4 		$248K Sell
9,100
-25,000
-73% -$1.14M ﹤0.01% 3409
2022
Q3 		$1.84M Sell
34,100
-4,200
-11% -$216K 0.01% 1755
2022
Q2 		$1.54M Buy
38,300
+13,000
+51% +$644K 0.01% 1877
2022
Q1 		$1.68M Buy
25,300
+21,700
+603% +$1.49M 0.01% 1807
2021
Q4 		$360K Sell
3,600
-2,500
-41% -$259K ﹤0.01% 3285
2021
Q3 		$763K Sell
6,100
-4,300
-41% -$511K ﹤0.01% 2499
2021
Q2 		$1.29M Sell
10,400
-3,100
-23% -$417K 0.01% 1884
2021
Q1 		$2.06M Buy
13,500
+8,100
+150% +$1.22M 0.01% 1299
2020
Q4 		$696K Sell
5,400
-17,800
-77% -$2.05M ﹤0.01% 2368
2020
Q3 		$2.59M Sell
23,200
-900
-4% -$82.3K 0.01% 952
2020
Q2 		$1.96M Buy
24,100
+22,800
+1,754% +$1.84M 0.01% 1117
2020
Q1 		$90K Sell
1,300
-31,500
-96% -$2.42M ﹤0.01% 3177
2019
Q4 		$2.56M Buy
32,800
+15,700
+92% +$1.13M 0.02% 1020
2019
Q3 		$1.09M Buy
17,100
+12,500
+272% +$1.1M 0.01% 1530
2019
Q2 		$397K Buy
+4,600
New +$351K ﹤0.01% 2377

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's GH Position: Q1 2025 in Review

Walleye Trading sold out of Guardant Health (GH) in Q1 2025, closing a stake of 1,600 shares — an estimated $69K sold.

Walleye Trading first reported a position in GH in Q2 2020 and held it in 11 quarters. The position peaked at $2.72M in Q1 2021. 341 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Walleye Trading reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 1,600 Guardant Health shares in Q1 2025, an estimated $69K.
  • Walleye Trading first reported a position in Guardant Health in Q2 2020 and held it in 11 quarters.
  • Walleye Trading's Guardant Health position peaked at $2.72M in Q1 2021.
  • 341 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.